About Knight Therapeutics
Knight Therapeutics is a company based in Westmount (Canada) founded in 2014. It operates as a Direct-to-Consumer (D2C), and HealthTech. The company has 165 employees as of December 31, 2024. Knight Therapeutics has completed 1 acquisition, including Biotoscana. Knight Therapeutics offers products and services including Specialty Pharmaceuticals and Impavido.
- Headquarter Westmount, Canada
- Employees 165 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Knight Therapeutics Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$5 M (USD), Debt – Conventional
Feb 20, 2019
-
Investors
-
Employee Count
165
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Knight Therapeutics
Knight Therapeutics is a publicly listed company on the TSX with ticker symbol GUD in Canada, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Knight Therapeutics
Knight Therapeutics offers a comprehensive portfolio of products and services, including Specialty Pharmaceuticals and Impavido. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Specialty drugs are developed for specific medical conditions.
Impavido is provided for treating specific parasitic infections.
Funding Insights of Knight Therapeutics
- Total Funding Total Funding
- Total Rounds 3
- Last Round Debt – Conventional — $5.0M
-
First Round
First Round
(10 Apr 2014)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2019 | Amount | Debt – Conventional - Knight Therapeutics | Valuation |
investors |
|
| Feb, 2017 | Amount | Post-IPO - Knight Therapeutics | Valuation |
investors |
|
| Apr, 2014 | Amount | Post-IPO - Knight Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Knight Therapeutics
Knight Therapeutics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Biotoscana. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Biotoscana is operated as a pharmaceutical company under Knight Therapeutics.
|
1984 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Knight Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Knight Therapeutics Comparisons
Competitors of Knight Therapeutics
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Knight Therapeutics
When was Knight Therapeutics founded?
Knight Therapeutics was founded in 2014.
Where is Knight Therapeutics located?
Knight Therapeutics is headquartered in Westmount, Canada. It is registered at Westmount, Quebec, Canada.
How many employees does Knight Therapeutics have?
As of Dec 31, 2024, the latest employee count at Knight Therapeutics is 165.
What does Knight Therapeutics do?
Knight Therapeutics Inc. is recognized as a leading pan-American specialty pharmaceutical company, excluding the US market. Operations are centered in Canada and Latin America, where innovative drugs and treatments are developed and distributed. The company is engaged in addressing specific medical needs through targeted pharmaceutical solutions. Various partnerships and investor relations are maintained to support growth and expansion across multiple countries in the region.
What products or services does Knight Therapeutics offer?
Knight Therapeutics offers Specialty Pharmaceuticals and Impavido.
Is Knight Therapeutics publicly traded?
Yes, Knight Therapeutics is publicly traded on TSX under the ticker symbol GUD.
How many acquisitions has Knight Therapeutics made?
Knight Therapeutics has made 1 acquisition, including Biotoscana.
What is Knight Therapeutics's ticker symbol?
The ticker symbol of Knight Therapeutics is GUD on TSX.